Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-009441·Elicio Therapeutics, Inc.
Schedule 13G ownership disclosure
Elicio Therapeutics, Inc.
Common Stock, par value $0.01 per share · CUSIP: 28657F103
Event date: 2025-01-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Knoll Capital Management, LLC
Shares: 630,915.00 · Class: 5.2%
- Fred Knoll
Shares: 630,915.00 · Class: 5.2%
- Gakasa Holdings, LLC
Shares: 630,915.00 · Class: 5.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-009441
- Form type
- SCHEDULE 13G
- Filer
- Elicio Therapeutics, Inc.
- CIK
- CIK 1601485
- Filed
- Feb 05, 2025
- Reporting period
- Jan 30, 2025
- Description
- Schedule 13G beneficial ownership